Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

5 Technologies to Reduce R&D Risk for Life Sciences

462 views

Published on

See the hottest life sciences tech here: https://ap.pn/2OfYF6r

The ability to reduce risk in the early stages of R&D is crucial to a successful and efficient drug development process. CROs and other life sciences organizations must focus on new, digital approaches to R&D that streamline processes and mitigate risk.

A recent Gartner report, surveying CIOs in life science organizations, found that digitalization not only helps to mitigate risk but also enables innovation in research. This is why CIOs are investing in digital technology in 2018 and beyond.

When asked which technology will drive differentiation…24 % of life science CIOs chose digitalization/digital marketing compared to 14 % of their cross-industry peers.

Here are the top five technologies that play an essential role in the future of the life sciences industry, especially for R&D.

Learn more about the latest platform technology for life sciences: https://ap.pn/2OfYF6r

Published in: Health & Medicine
  • Be the first to comment

  • Be the first to like this

5 Technologies to Reduce R&D Risk for Life Sciences

  1. 1. 5 Technologies to Reduce R&D Risk for Life Sciences The Importance of Reducing Risk The Crucial Role of Digitalization/ Digital Marketing in Life Sciences The ability to reduce risk in the early stages of R&D is crucial to a successful and efficient drug development process. Top 5 Technologies That Play an Essential Role in the Future of the Life Sciences Industry When asked which technology will drive differentiation 24 % of life science CIOs choose digitalization/digital marketing compared to 14 % of their cross-industry peers. Analytics allow organizations to make more informed decisions based off of patient data, providing more beneficial drugs to the patient and more competitive success for the company. IoT streamlines inefficient processes throughout drug development and can potentially help bring costs down across the system. Digitalization of processes improves efficiency and minimizes human error, which could significantly reduce cycle and development times. BI/Analytics Digitalization Internet of Things Cloud offers assurance that needed resources will always be available for quick implementation. This capability not only lends to maintaining compliance, but also contributes to improving speed to market. Want to see how Appian is using these technologies to contribute to a more successful digital transformation? Visit our Life Sciences resource center. AI helps streamline the drug development process by leveraging consumer data to better understand customer segments and determine the best course of action. Artificial Intelligence Cloud Services/Solutions Appian’s Solutions twitter.com/appian facebook.com/AppianCorporation linkedin.com/company/appian-corporation youtube.com/appian www.appian.com/life-sciences appian.com/blog About Appian Appian runs a business process management cloud platform that helps companies optimize their operations. 1 2 3 4 5 BI/Analytics Digitalization Internet of Things Artificial Intelligence Cloud services/solutions www.appian.com/life-sciences

×